COSYNE THERAPEUTICS Trademark

Trademark Overview


On Wednesday, May 25, 2022, a trademark application was filed for COSYNE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the COSYNE THERAPEUTICS trademark a serial number of 97427191. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Friday, July 18, 2025. This trademark is owned by CoSyne Therapeutics Limited. The COSYNE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, neurological and oncological pharmaceutical products; Pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer

Drug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development purposes
cosyne therapeutics

General Information


Serial Number97427191
Word MarkCOSYNE THERAPEUTICS
Filing DateWednesday, May 25, 2022
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 9, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized wording "COSYNE"over the stylized wording "THERAPEUTICS" with the design of a DNA helix forming the letter "Y" extending downward to also form the letter "A".
Goods and ServicesPharmaceuticals, namely, neurological and oncological pharmaceutical products; Pharmaceuticals, namely, neurological and oncological pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of neurological diseases and cancer; pharmaceutical products for the treatment and prevention of neurological diseases and cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDrug discovery services; Scientific research for medical purposes in the fields of neuroscience, genetics and computational analysis, and cancer; research and development of pharmaceuticals for the treatment of neurological diseases and cancer; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development; medical research; pharmaceutical testing, pre-clinical research, clinical research, and clinical trials for pharmaceutical product development purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCoSyne Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Party NameCoSyne Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLondon WIF8BH
GB

Trademark Events


Event DateEvent Description
Saturday, May 28, 2022NEW APPLICATION ENTERED
Wednesday, June 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 2, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023NON-FINAL ACTION WRITTEN
Friday, March 10, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 9, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 9, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 4, 2024SOU EXTENSION 1 FILED
Thursday, January 4, 2024SOU EXTENSION 1 GRANTED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 5, 2024SOU EXTENSION 2 GRANTED
Friday, July 5, 2024SOU EXTENSION 2 FILED
Wednesday, July 2, 2025NOTICE OF REVIVAL - E-MAILED
Wednesday, July 2, 2025PETITION TO REVIVE-GRANTED
Wednesday, July 2, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Friday, July 18, 2025TEAS PETITION TO REVIVE RECEIVED
Friday, July 18, 2025NOTICE OF REVIVAL - E-MAILED
Friday, July 18, 2025PETITION TO REVIVE-GRANTED
Friday, July 18, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, July 2, 2025TEAS PETITION TO REVIVE RECEIVED